• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性切除术后壶腹癌长期生存的预后因素。

Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.

机构信息

Postgraduate Program in Medicine: Surgical Sciences, Medical School of Universidade Federal do Rio Grande do Sul - (FAMED-UFRGS), Porto Alegre, RS, Brazil.

Postgraduate Program in Genetics and Molecular Biology, Medical School of Universidade Federal do Rio Grande do Sul - (FAMED-UFRGS), Porto Alegre, RS, Brazil.

出版信息

J Gastrointest Cancer. 2021 Sep;52(3):872-881. doi: 10.1007/s12029-020-00479-9.

DOI:10.1007/s12029-020-00479-9
PMID:32808236
Abstract

BACKGROUND

The incidence of adenocarcinoma of the ampulla of Vater has been increasing over the past years. Nevertheless, it is still a rare disease and the prognostic factors predicting long-term survival are not sufficiently clarified. This study aims to evaluate the association between histopathological characteristics and long-term survival of patients with ampullary cancer after curative resection, as well as the efficiency of immunohistochemical expression of CK7, CK20, and CDX2 to distinguish the histopathological (intestinal or pancreaticobiliary) patterns.

METHODS

Demographic, histopathological data, pTNM stage, and immunohistochemical expression patterns were collected from 65 patients with adenocarcinoma of the ampulla of Vater. Five and 10-year overall and disease-free survival rates after curative resection were determined.

RESULTS

Of the 65 patients with ampullary carcinoma, 47 (72%) underwent radical resection. The 5- and 10-year overall survival rate was 46% and 37%, respectively. Our results demonstrate that the main prognostic factors were the presence and number of lymph node metastases, lymph node ratio (LNR), differentiation grade, and lymphovascular invasion. After multivariate analysis, only lymph node ratio ≥ 20% remained an independent prognostic factor of survival (HR: 2.63 95% CI: 1.05-6.61; p = 0.039).

CONCLUSION

Here, we demonstrated more evidence that the lymph node metastases are associated with poor prognosis in ampullary carcinoma. Particularly, the relation between the number of metastatic lymph nodes and the number of harvested lymph node (LNR) should be considered a major prognostic factor.

摘要

背景

近年来, Vater 壶腹腺癌的发病率一直在上升。然而,它仍然是一种罕见的疾病,预测长期生存的预后因素尚不清楚。本研究旨在评估根治性切除术后壶腹癌患者的组织病理学特征与长期生存之间的关系,以及 CK7、CK20 和 CDX2 的免疫组织化学表达区分组织病理学(肠或胰胆管)模式的效率。

方法

收集 65 例 Vater 壶腹腺癌患者的人口统计学、组织病理学数据、pTNM 分期和免疫组织化学表达模式。确定根治性切除术后的 5 年和 10 年总生存率和无病生存率。

结果

在 65 例壶腹癌患者中,47 例(72%)接受了根治性切除术。5 年和 10 年的总生存率分别为 46%和 37%。我们的结果表明,主要的预后因素是淋巴结转移的存在和数量、淋巴结比率(LNR)、分化程度和血管淋巴管侵犯。多因素分析后,只有淋巴结比率≥20%仍然是生存的独立预后因素(HR:2.63 95%CI:1.05-6.61;p=0.039)。

结论

我们的研究结果进一步证明了淋巴结转移与壶腹癌预后不良相关。特别是,转移淋巴结的数量与采集的淋巴结数量(LNR)之间的关系应被视为主要的预后因素。

相似文献

1
Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.根治性切除术后壶腹癌长期生存的预后因素。
J Gastrointest Cancer. 2021 Sep;52(3):872-881. doi: 10.1007/s12029-020-00479-9.
2
[Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].免疫组化标志物联合应用鉴别壶腹癌病理亚型及其临床意义
Zhonghua Bing Li Xue Za Zhi. 2019 Feb 8;48(2):92-97. doi: 10.3760/cma.j.issn.0529-5807.2019.02.003.
3
Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.CK7和CK20免疫组化表达对根治性切除的 Vater壶腹癌的预后影响
BMC Gastroenterol. 2015 Nov 24;15:165. doi: 10.1186/s12876-015-0396-x.
4
Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.β-连环蛋白、表皮生长因子受体、细胞角蛋白7、细胞角蛋白20、黏蛋白1、黏蛋白2和尾型同源盒转录因子2在肠道型和胰胆管型壶腹癌中的差异表达
Int J Surg Pathol. 2017 Feb;25(1):31-40. doi: 10.1177/1066896916664987. Epub 2016 Aug 20.
5
Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.淋巴结侵犯而非组织病理学亚型与 Vater 壶腹腺癌切除术后的结局相关。
J Gastrointest Surg. 2010 Apr;14(4):719-28. doi: 10.1007/s11605-010-1156-4. Epub 2010 Jan 27.
6
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.壶腹癌根治性切除术后淋巴结比率及切除淋巴结数量的预后相关性
Ann Surg Oncol. 2008 Nov;15(11):3178-86. doi: 10.1245/s10434-008-0099-4. Epub 2008 Aug 20.
7
The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.淋巴结在壶腹癌根治性切除术后预后预测中的作用。
World J Surg Oncol. 2015 Jul 25;13:224. doi: 10.1186/s12957-015-0643-1.
8
Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.根治性切除联合辅助治疗后壶腹腺癌患者淋巴结状态的预后相关性
Eur J Surg Oncol. 2017 Sep;43(9):1690-1696. doi: 10.1016/j.ejso.2017.05.024. Epub 2017 Jun 15.
9
[Prognostic factors in adenocarcinoma of the ampulla of Vater].[ Vater壶腹腺癌的预后因素]
Rev Esp Patol. 2018 Oct-Dec;51(4):210-215. doi: 10.1016/j.patol.2018.03.001. Epub 2018 Apr 13.
10
The clinical significance of the lymph node ratio as a recurrence indicator in ampullary cancer after curative pancreaticoduodenectomy.淋巴结比率作为胰十二指肠切除术后壶腹癌复发指标的临床意义。
Langenbecks Arch Surg. 2024 Oct 8;409(1):302. doi: 10.1007/s00423-024-03481-y.

引用本文的文献

1
Effect of MELD-Na score on overall survival of periampullary cancer.MELD-Na 评分对壶腹周围癌总生存的影响。
Updates Surg. 2024 Sep;76(5):1819-1825. doi: 10.1007/s13304-024-01856-w. Epub 2024 May 7.
2
Prediction of tumor recurrence after surgical resection of ampullary adenocarcinoma using magnetic resonance imaging.使用磁共振成像预测壶腹腺癌手术后的肿瘤复发。
Eur Radiol. 2024 Oct;34(10):6929-6939. doi: 10.1007/s00330-024-10713-8. Epub 2024 Mar 27.
3
Predictive Factors Associated With Survival in Periampullary Cancers Following Pancreaticoduodenectomy: A Retrospective Analysis.

本文引用的文献

1
Development and validation of a nomogram for predicting overall survival of node-negative ampullary carcinoma.列线图预测无淋巴结转移壶腹癌总生存的构建与验证。
J Surg Oncol. 2020 Mar;121(3):518-523. doi: 10.1002/jso.25816. Epub 2019 Dec 26.
2
Prognostic Nomogram for Disease-Specific Survival in Patients with Non-metastatic Ampullary Carcinoma After Surgery.术后非转移性壶腹癌患者疾病特异性生存的预后列线图。
Ann Surg Oncol. 2019 Apr;26(4):1079-1085. doi: 10.1245/s10434-018-07115-8. Epub 2019 Jan 18.
3
Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma.
胰十二指肠切除术后壶腹周围癌生存相关的预测因素:一项回顾性分析
Cureus. 2023 Dec 15;15(12):e50607. doi: 10.7759/cureus.50607. eCollection 2023 Dec.
4
Machine learning models for predicting survival in patients with ampullary adenocarcinoma.用于预测壶腹腺癌患者生存率的机器学习模型。
Asia Pac J Oncol Nurs. 2022 Sep 5;9(12):100141. doi: 10.1016/j.apjon.2022.100141. eCollection 2022 Dec.
5
Screening for hilar biliary invasion in ampullary cancer patients.壶腹癌患者肝门部胆管侵犯的筛查
World J Gastrointest Endosc. 2022 Sep 16;14(9):536-546. doi: 10.4253/wjge.v14.i9.536.
6
Prognostic Value of the Regional Lymph Node Station in Pancreatoduodenectomy for Ampullary Carcinoma.胰十二指肠切除术治疗壶腹癌时区域淋巴结站的预后价值。
In Vivo. 2022 Mar-Apr;36(2):973-978. doi: 10.21873/invivo.12789.
7
Clinicopathological Prognostic Factors and Chemotherapeutic Outcome for Two Histopathological Types of Ampulla of Vater Adenocarcinoma.两种组织病理学类型的 Vater 壶腹腺癌的临床病理预后因素及化疗结果
Front Oncol. 2021 Feb 18;11:616108. doi: 10.3389/fonc.2021.616108. eCollection 2021.
第八版美国癌症联合委员会胆管癌分期系统的验证。
Cancer Res Treat. 2019 Jan;51(1):98-111. doi: 10.4143/crt.2017.595. Epub 2018 Mar 2.
4
Validation of the eighth edition of the American Joint Committee on Cancer staging system for ampulla of Vater cancer.验证第八版美国癌症联合委员会(AJCC)壶腹癌分期系统。
Surgery. 2018 May;163(5):1071-1079. doi: 10.1016/j.surg.2017.12.018. Epub 2018 Feb 13.
5
Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.根治性切除联合辅助治疗后壶腹腺癌患者淋巴结状态的预后相关性
Eur J Surg Oncol. 2017 Sep;43(9):1690-1696. doi: 10.1016/j.ejso.2017.05.024. Epub 2017 Jun 15.
6
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.第八版 AJCC 癌症分期手册:继续从基于人群的方法向更“个体化”的癌症分期方法构建桥梁。
CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17.
7
Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.在III期结直肠癌中,阴性淋巴结与阳性淋巴结比例比传统的淋巴结状态是更好的预测指标。
Oncotarget. 2016 Nov 1;7(44):72290-72299. doi: 10.18632/oncotarget.10806.
8
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma.评估淋巴结比率以取代食管癌 TNM 系统的 pN 分类系统。
J Thorac Oncol. 2016 Oct;11(10):1774-84. doi: 10.1016/j.jtho.2016.06.019. Epub 2016 Jul 5.
9
Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center.基于淋巴结比率的分期系统在2575例胃癌患者预后预测中的优越性:大型单中心验证分析
Oncotarget. 2016 Aug 9;7(32):51069-51081. doi: 10.18632/oncotarget.9714.
10
Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.壶腹腺癌中KRAS、BRAF和PIK3CA突变的低发生率及其预后价值。
Hum Pathol. 2016 Apr;50:90-100. doi: 10.1016/j.humpath.2015.11.009. Epub 2015 Nov 30.